Octave Bioscience
Latest round
- Series C
Last raised
- Mar 2025
Total raised
- $110M
Investors
- 12
About Octave Bioscience
Founded in 2014 in Menlo Park, US, Octave Bioscience Inc develops diagnostic solutions for neurodegenerative diseases. Fox Foundation.Octave Bioscience, Inc. specializes in providing innovative diagnostic solutions aimed at enhancing the management of Multiple Sclerosis (MS) and other neurodegenerative diseases. Central to their offerings is the MSDA Test, a simple and accessible blood test that generates clinically relevant insights regarding MS disease activity. This test is designed to assist healthcare professionals in making informed clinical decisions, such as initiating, modifying, or halting disease-modifying therapies (DMT) and determining the necessity for further laboratory or MRI assessments. The company serves a diverse client base, primarily healthcare providers and clinicians involved in the management of MS, ensuring that they have access to valuable data that can inform treatment pathways.Octave Bioscience generates revenue through a model that emphasizes direct engagement with healthcare providers and institutions. The company’s flagship offering, the MSDA Test, is structured as a fee-for-service transaction, where clinicians order the test for their patients, and Octave charges a set fee per test conducted. This transactional model facilitates B2B relationships, allowing healthcare providers to incorporate the test into their diagnostic processes. The company may also pursue partnerships with healthcare systems and academic institutions to further expand its reach and enhance its service offerings. Revenue is derived from the direct submission of test orders by clinicians, reflecting the test's significance in clinical decision-making and the ongoing need for reliable diagnostic tools in the evolving field of neurology.
Who invested in Octave Bioscience
12 investors across 4 rounds
See all investors in Octave Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Octave Bioscience
Who invested in Octave Bioscience?
Octave Bioscience has 12 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Octave Bioscience raised?
Octave Bioscience has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Octave Bioscience last raise money?
Octave Bioscience's most recent round on record is a Series C, in Mar 2025.
What does Octave Bioscience do?
Founded in 2014 in Menlo Park, US, Octave Bioscience Inc develops diagnostic solutions for neurodegenerative diseases.
Where is Octave Bioscience headquartered?
Octave Bioscience is headquartered in Menlo Park, US.
Which VCs invest in companies like Octave Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Octave Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Octave Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.